Abstract

The IEDB, www.iedb.org, contains information on immune epitopes—the molecular targets of adaptive immune responses—curated from the published literature and submitted by National Institutes of Health funded epitope discovery efforts. From 2004 to 2012 the IEDB curation of journal articles published since 1960 has caught up to the present day, with >95% of relevant published literature manually curated amounting to more than 15 000 journal articles and more than 704 000 experiments to date. The revised curation target since 2012 has been to make recent research findings quickly available in the IEDB and thereby ensure that it continues to be an up-to-date resource. Having gathered a comprehensive dataset in the IEDB, a complete redesign of the query and reporting interface has been performed in the IEDB 3.0 release to improve how end users can access this information in an intuitive and biologically accurate manner. We here present this most recent release of the IEDB and describe the user testing procedures as well as the use of external ontologies that have enabled it.

Highlights

  • The IEDB was established in 2004, and over the past 10 years our team has manually curated almost 16 000 published manuscripts and processed 200 direct submissions

  • All publications describing the 3D structure of an epitope in complex with its adaptive immune receptor or major histocompatibility complex (MHC) molecule are included regardless of origin of the epitope in order to provide a complete dataset of this valuable type of information

  • The driving force behind the IEDB 3.0 redesign has been user feedback accumulated since the 2.0 release of the IEDB in 2009 (2)

Read more

Summary

Introduction

The IEDB was established in 2004, and over the past 10 years our team has manually curated almost 16 000 published manuscripts and processed 200 direct submissions. Examples include: use of NCBI Taxonomy (4) to describe organisms, GenBank (5) and UniProt (6) for proteins, ChEBI (3) for non-peptidic structures, the Ontology for Biomedical Investigations (OBI) (7) for assay types, Gazetteer (http: //purl.bioontology.org/ontology/GAZ) for geographic location and the Human Disease Ontology (8) for diseases.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.